These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 36271678)

  • 1. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau protein profiling in tauopathies: a human brain study.
    Lantero-Rodriguez J; Camporesi E; Montoliu-Gaya L; Gobom J; Piotrowska D; Olsson M; Burmann IM; Becker B; Brinkmalm A; Burmann BM; Perkinton M; Ashton NJ; Fox NC; Lashley T; Zetterberg H; Blennow K; Brinkmalm G
    Mol Neurodegener; 2024 Jul; 19(1):54. PubMed ID: 39026372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus).
    Takaichi Y; Chambers JK; Takahashi K; Soeda Y; Koike R; Katsumata E; Kita C; Matsuda F; Haritani M; Takashima A; Nakayama H; Uchida K
    Acta Neuropathol Commun; 2021 Jan; 9(1):10. PubMed ID: 33413691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.
    Horie K; Li Y; Barthélemy NR; Gordon B; Hassenstab J; Benzinger TLS; Fagan AM; Morris JC; Karch CM; Xiong C; Allegri R; Mendez PC; Ikeuchi T; Kasuga K; Noble J; Farlow M; Chhatwal J; Day G; Schofield PR; Masters CL; Levin J; Jucker M; Lee JH; Roh JH; Sato C; Sachdev P; Koyama A; Reyderman L; Bateman RJ; McDade E;
    Ann Neurol; 2023 Jun; 93(6):1158-1172. PubMed ID: 36843330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.
    Diner I; Nguyen T; Seyfried NT
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease.
    Roberts M; Sevastou I; Imaizumi Y; Mistry K; Talma S; Dey M; Gartlon J; Ochiai H; Zhou Z; Akasofu S; Tokuhara N; Ogo M; Aoyama M; Aoyagi H; Strand K; Sajedi E; Agarwala KL; Spidel J; Albone E; Horie K; Staddon JM; de Silva R
    Acta Neuropathol Commun; 2020 Feb; 8(1):13. PubMed ID: 32019610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice.
    Davtyan H; Hovakimyan A; Kiani Shabestari S; Antonyan T; Coburn MA; Zagorski K; Chailyan G; Petrushina I; Svystun O; Danhash E; Petrovsky N; Cribbs DH; Agadjanyan MG; Blurton-Jones M; Ghochikyan A
    Alzheimers Res Ther; 2019 Dec; 11(1):107. PubMed ID: 31847886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
    Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
    Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
    J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.
    Guo JP; Arai T; Miklossy J; McGeer PL
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1953-8. PubMed ID: 16446437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
    Thygesen C; Metaxas A; Larsen MR; Finsen B
    J Alzheimers Dis; 2018; 64(4):1247-1259. PubMed ID: 29991132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.